Literature DB >> 2461364

Functional properties of human skeletal muscle acetylcholine receptors expressed by the TE671 cell line.

S M Sine1.   

Abstract

Functional properties of acetylcholine receptors from intact TE671 human medulloblastoma cells were examined using tracer ion flux, ligand competition against 125I-labeled alpha-bungarotoxin binding, and single channel recording measurements. 125I-Labeled alpha-bungarotoxin binds to surface receptors with the forward rate constant 1.8 X 10(5) M-1 s-1 and dissociates with the rate constant 4.6 X 10(-5) s-1, at 21 degrees C; the apparent dissociation constant is 2.6 X 10(-10) M. alpha-Bungarotoxin binds to at least two sites/receptor, but blocks agonist-induced 22Na+ uptake when bound to only one site. The reversible antagonists, dimethyl-d-tubocurarine and gallamine, occupy two sites which exhibit nearly equivalent affinities, but block agonist-induced uptake by occupying only one site. Strong agonists activate rapid sodium uptake with relatively low affinity, but desensitize with a much higher affinity; among agonists, the ratio of low to high affinity dissociation constants ranges from 1600 to 4000. By using the estimated dissociation constants, the allosteric model of Monod, Wyman, and Changeux (MWC) can be fitted to the concentration dependencies of both steady-state agonist occupancy and desensitization. The fitting analysis discloses an allosteric constant of 3 X 10(-5), which is the ratio of activatable to desensitized receptors in the absence of agonist. The rate of recovery from desensitization can exceed the rate of onset of desensitization elicited by low concentrations of agonist, further supporting the general MWC framework. Single channel recordings show that the channel opening probability is greater than 0.7 at high agonist concentrations. Favorable channel opening is shown to only slightly oppose strong desensitization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461364

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Activation of skeletal muscle nicotinic acetylcholine receptors.

Authors:  C J Lingle; D Maconochie; J H Steinbach
Journal:  J Membr Biol       Date:  1992-03       Impact factor: 1.843

2.  Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity.

Authors:  S M Sine
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

3.  Functional and non-functional isoforms of the human muscle acetylcholine receptor.

Authors:  C F Newland; D Beeson; A Vincent; J Newsom-Davis
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

4.  Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.

Authors:  Kathryn H Ching; Peter D Burbelo; Richard M Kimball; Lora L Clawson; Andrea M Corse; Michael J Iadarola
Journal:  Neuromuscul Disord       Date:  2010-12-30       Impact factor: 4.296

5.  The short-neurotoxin-binding regions on the alpha-chain of human and Torpedo californica acetylcholine receptors.

Authors:  K H Ruan; B G Stiles; M Z Atassi
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

6.  Changes in channel properties of acetylcholine receptors during the time course of thiol chemical modifications.

Authors:  C Bouzat; F J Barrantes; F J Sigworth
Journal:  Pflugers Arch       Date:  1991-03       Impact factor: 3.657

7.  Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine.

Authors:  J Bufler; R Wilhelm; H Parnas; C Franke; J Dudel
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

8.  Bisindole alkaloids from Strychnos guianensis are effective antagonists of nicotinic acetylcholine receptors in cultured human TE671 cells.

Authors:  Pierre Wins; Ilca Margineanu; Jacques Penelle; Luc Angenot; Thierry Grisar; Lucien Bettendorff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-19       Impact factor: 3.000

9.  Kinetics of (+)-tubocurarine blockade at the neuromuscular junction.

Authors:  A C Le Dain; B W Madsen; R O Edeson
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

10.  Development of an assay for modulating anti-acetylcholine receptor autoantibodies using human rhabdomyosarcoma cell line.

Authors:  B W Lyons; L L Wu; M E Astill; J T Wu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.